Search - tctmd.com

Displaying 181 - 200 of 901

Sort: Relevancy | Date

News Conference News ACC 2020

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

Yael L. Maxwell

March 29, 2020

News Conference News ACC 2020

UK TAVI: Real-world TAVR and SAVR Have Similar 1-Year Mortality

L.A. McKeown

March 29, 2020

News Daily News

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

Michael O'Riordan

March 17, 2020

News Conference News CRT 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Michael O'Riordan

February 27, 2020

Podcast TCTMD Talking Points

SCOPE I: ACURATE Neo vs SAPIEN 3 in Severe Aortic Stenosis

January 22, 2020

News Opinion Editor's Corner

The Biggest News of 2019: TCTMD’s Top 10

Shelley Wood

January 01, 2020

News Conference News PCR London Valves 2019

Signal of Impaired Sapien XT Durability in Midterm Follow-up

Michael O'Riordan

November 20, 2019

News Conference News AHA 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Yael L. Maxwell

November 18, 2019

News Daily News

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Michael O'Riordan

November 06, 2019

News Industry News

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

November 06, 2019

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Shelley Wood

October 08, 2019

News Conference News TCT 2019

Predicting Final Valve Position After TAVR: Different Devices, Different Success

Michael O'Riordan

October 07, 2019

Presentation TCT Abstracts Posters 2019

A Non-Invasive Approach for Assessment the Severity of Paravalvular Leakage and Transvalvular Energy Loss using Echocardiography

Presenter: Mohammed Baraket

October 03, 2019

Presentation TCT Abstracts Posters 2019

Structural Analysis of Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valves

Presenter: Dong Qiu

October 02, 2019

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

Todd Neale

September 29, 2019

Presentation TCT 2019

TCT 8: Updated 30-Day Outcomes for the U.S. Early Feasibility Study of the SAPIEN M3 Transcatheter Mitral Valve Replacement System

Presenter: Brian Whisenant

September 28, 2019

News Conference News TCT 2019

Portico Noninferior to Commercial TAVR Valves in IDE Study

Caitlin E. Cox

September 27, 2019

News Conference News TCT 2019

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Marcus A. Banks

September 27, 2019

News Conference News TCT 2019

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Yael L. Maxwell

September 27, 2019

Advertisement

PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients

UK TAVI: Real-world TAVR and SAVR Have Similar 1-Year Mortality

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

SCOPE I: ACURATE Neo vs SAPIEN 3 in Severe Aortic Stenosis

The Biggest News of 2019: TCTMD’s Top 10

Signal of Impaired Sapien XT Durability in Midterm Follow-up

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Sapien 3 Valve Approved in Europe for Low-Risk Patients

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

Predicting Final Valve Position After TAVR: Different Devices, Different Success

A Non-Invasive Approach for Assessment the Severity of Paravalvular Leakage and Transvalvular Energy Loss using Echocardiography

Structural Analysis of Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valves

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

TCT 8: Updated 30-Day Outcomes for the U.S. Early Feasibility Study of the SAPIEN M3 Transcatheter Mitral Valve Replacement System

Portico Noninferior to Commercial TAVR Valves in IDE Study

SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content